mammography imaging News
-
Aidoc And Screenpoint Medical Announce Partnership To Provide Complete Ai Solution For Breast Imaging
Aidoc’s comprehensive AI continues to expand to cover the majority of radiology adult subspecialties Aidoc, the leading provider of AI for medical imaging, and ScreenPoint Medical, leader of deep learning AI for 2D and 3D mammography, today announced a collaboration which will incorporate ScreenPoint’s capabilities into Aidoc’s platform. Breast imaging specialists will now be ...
By Aidoc
-
AMA recognizes Dedicated Breast CT by assigning 6 CPT Codes
On June 15th, 2020, the American Medical Association (AMA) granted 6 Category III CPT codes for the FDA PMA cleared dedicated breast CT imaging procedure. The newly assigned CPT codes in addition to the previous FDA PMA clearance process, formally introduces access to this new and advanced modality on January 1, 2021. The AMA technical subcommittee, comprised of prominent members of the ...
-
Aurora Technology and Healthcare Global Holdings enters the 2nd most populous continent through a collaboration with the Federal Republic of Nigeria to transform breast cancer care in Africa
Aurora Technology and Healthcare Global Holdings enters the 2nd most populous continent through a collaboration with the Federal Republic of Nigeria to transform breast cancer care in Africa New York, Abuja, Boston: Representatives of the Nigerian government and Aurora Technology and Healthcare Global Holding Corp. (Aurora) are jointly announcing the signing of a landmark collaboration ...
-
Icecure Medical announces new independent data published in the journal of cancer therapy showing that percutaneous Cryoablation presents a potential substitute for lumpectomy for tumors <15mm using Prosense
IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced that a peer reviewed article titled, “VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in ...
-
InHealth (North and East Devon NHS Breast Screening Unit) signing up to the AI in Health & Care Award with Kheiron Medical Technologies
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence in NHS breast cancer screening. ...
-
Ultravist by Bayer now approved for contrast-enhanced mammography in EU
Ultravist-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure CEM is emerging modality combining digital mammography with the administration of a contrast agent Strategically expands Bayer’s portfolio in breast imaging, including contrast agents and injectors Bayer announced today that its ...
By Bayer AG
-
Seno Medical’s Imagio Breast Imaging System Named Science and Medical Category Finalist in 2022 Edison Awards Program
Seno Medical’s Imagio Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category and Diagnostics sub-category. The Edison Awards program is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. Past winners have included Fortune 500s, small start-ups, ...
-
FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. (Seno) premarket approval (PMA) for its groundbreaking diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company’s Imagio® Breast Imaging System ...
-
Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Conf
A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone. The poster, “Performance of Optoacoustic Ultrasound with an Artificial Intelligence-based Decision Support Tool vs ...
-
Seno Medical Launches CONFIDENCE Registry Study for Imagio® Breast Imaging System
Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with opto-acoustic/ultrasound (OA/US) to diagnose breast abnormalities including cancer using its groundbreaking Imagio® Breast Imaging System. Approximately twelve sites will participate in the international registry, with a target of over 600 total patients ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you